Related Experiment Video
Updated: May 25, 2026

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
A comparative trial use of sulpiride and risperidone in Huntington's disease: a pilot study
M A Reveley1, S M Dursun, H Andrews
1Department of Psychiatry, Robert Kilpatrick Clinical Sciences Building, Faculty of Medicine, University of Leicester, Leicester LE2 7LX, UK.
Abstract:
Sulpiride and risperidone treatment significantly improved the abnormal involuntary movements of two patients with Huntington's disease on both actometer and clinical assessments. However, treatment with risperidone, but not sulpiride, significantly improved the functional activities as assessed by the Functional Disability Scale. To the best of our knowledge this is the first report of the successful treatment of Huntington's disease with risperidone.
Related Concept Videos
Huntington Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
